The pressure has been mounting for the Government to fund high cost drugs, especially for cancer car...
The pressure has been mounting for the Government to fund high cost drugs, especially for cancer care. Initially its line was that only drugs approved by the National Institute of Clinical Health and Excellence (NICE) would be paid for but some discretion was allowed to individual clinicians, Primary Care Trusts and hospitals. Then came Herceptin, where the former Secretary of State was forced to accelerate matters for a group of patients. Around that time Western Provident Association obtained a QC's opinion that patients would be entitled to fund their drugs privately without affecting th...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes